MYASTHENIA GRAVIS

This study looked at the long-term safety of a drug called HBM9161 for people with generalized myasthenia gravis, a condition that causes muscle weakness. It involved 111 patients who had already completed a previous phase 3 study. The goal was to see if the drug is safe to use o…

This study looked at whether having a tendency toward depression affects how well people with thymoma-associated myasthenia gravis (MG) respond to psychological counseling. Nineteen adults who had surgery for thymoma and MG received eight sessions of counseling based on Gestalt t…

This study tested an online program to improve mental health in people with myasthenia gravis, a chronic muscle weakness condition. 77 patients completed a four-month program of short videos on Facebook about building social support, emotional awareness, and self-worth. Researche…

This study tested whether acupuncture can improve quality of life and daily activities for people with myasthenia gravis, a condition that causes muscle weakness. Twenty-four adults received acupuncture twice a week for 12 weeks, with some starting immediately and others after a …

This completed study enrolled 311 people with myasthenia gravis, a condition that causes muscle weakness. Researchers collected clinical information and blood samples to build a repository for future studies. The goal is to help scientists better understand the disease and potent…

This completed study looked at how common cognitive (thinking) difficulties are in 150 people with myasthenia gravis. Researchers measured memory, attention, and other mental skills, and how these issues affect daily activities, work, and quality of life. The goal is to better un…

This study reviewed medical records of 100 people with myasthenia gravis who had thymus gland surgery. Researchers compared those with and without a thymus tumor to see what factors helped predict a full recovery. The goal was to better understand who benefits most from this proc…

This study tested a new sustained-release (long-acting) version of pyridostigmine, a drug used for myasthenia gravis (a muscle weakness disease). Forty healthy Chinese adults took both the new long-acting tablet and the standard immediate-release tablet at different times to comp…